2012
DOI: 10.1016/j.fertnstert.2012.08.015
|View full text |Cite
|
Sign up to set email alerts
|

CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
15
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 39 publications
5
15
0
Order By: Relevance
“…In addition, the increased T cell proportion was mainly caused by the increased proportion of CD4+T cells. Previous studies have revealed that CD4+T cells are elevated in women with PCOS, 21,22 which was in accordance with our results. However, the changes in T lymphocyte subsets in patients with PCOS remain controversial at present.…”
Section: Discussionsupporting
confidence: 94%
“…In addition, the increased T cell proportion was mainly caused by the increased proportion of CD4+T cells. Previous studies have revealed that CD4+T cells are elevated in women with PCOS, 21,22 which was in accordance with our results. However, the changes in T lymphocyte subsets in patients with PCOS remain controversial at present.…”
Section: Discussionsupporting
confidence: 94%
“…1). Consistent with previous reports, there were no disturbances in the percentages of CD4 + T cells in PCOS patients with infertility 31 . Although the percentage of CD4 + T cells did not change in PCOS patients with infertility, both CD4 + and CD8 + T cells expressed significantly lower levels of CD69 in the PCOS group ( P < 0.01, Fig.…”
Section: Discussionsupporting
confidence: 92%
“…Our group previously demonstrated the absence of differences in terms of total lymphocyte count and total CD4 þ T-cell frequency between women with PCOS and control women. 9 We further confirmed these results in a recent article of Moro et al 21 At present, insulin-sensitizing drugs, such as metformin, represent one of the most important line treatments for women with hyperinsulinemic PCOS. Metformin is able to produce favorable outcomes on the metabolic derangements in insulin-resistant normal weight and obese patients with PCOS.…”
Section: Introductionsupporting
confidence: 84%